Knoll Capital Management’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Knoll Capital Management’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-27,430	Closed	-$62K	–	17
2014 Q2	$62K	Sell	27,430 -1,200	-4%	-$2.98K	0.03%	15
2014 Q1	$86K	Sell	28,630 -15,815	-36%	-$52.1K	0.04%	16
2013 Q4	$140K	Hold	44,445	–	–	0.07%	14
2013 Q3	$123K	Sell	44,445 -400,000	-90%	-$1.08M	0.07%	11
2013 Q2	$111K	Buy	+444,445	New	+$2.33M	0.08%	11

Other funds holding ECTE

Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

EEG

E.E. Geduld $178M AUM 29.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NPC

National Planning Corporation El Segundo, California $726K AUM 14.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Knoll Capital Management's ECTE Position: Q3 2014 in Review

Knoll Capital Management sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2014, closing a stake of 27,430 shares — an estimated $62K sold.

Knoll Capital Management first reported a position in ECTE in Q2 2013 and held it in 5 quarters. The position peaked at $140K in Q4 2013. 26 funds tracked by Wall St. Rank hold ECTE as of Q3 2014.

Knoll Capital Management reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2014 after selling out during the quarter.
Knoll Capital Management sold 27,430 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2014, an estimated $62K.
Knoll Capital Management first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 5 quarters.
Knoll Capital Management's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $140K in Q4 2013.
26 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2014.

Based on Knoll Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.